[Hormonal therapy of breast carcinoma in women].
Possinger
K
K
GSF-Institut für Klinische Hämatologie, Klinikum Grosshadern, Universität München.
Classen
S
S
Beykirch
M
M
Flath
B
B
Wilmanns
W
W
D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D004341:Drug Evaluation; D004347:Drug Interactions; D004965:Estrogen Antagonists / Q000493:pharmacokinetics / Q000627:therapeutic use; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use; D006728:Hormones / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D011372:Progestins / Q000037:antagonists & inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use
D047072:Aromatase Inhibitors; D004965:Estrogen Antagonists; D006728:Hormones; D011372:Progestins; D007987:Gonadotropin-Releasing Hormone
Hormontherapie beim metastasierten Mammakarzinom der Frau.